NexPharma AB

Active
559492-6023Limited company (AB)Registered 2024RÖNNINGE

Key figures

1 047 765 kr+163,6%
Revenue 2025/26
+163,6%
Average annual growth 2024/25–2025/26
0500 k1 m1,5 m2024/252025/26

Key figures

2025/26

Summary: NexPharma AB

What kind of company is it?

NexPharma AB (org. no. 559492-6023) is a limited company (AB). The company was registered in 2024 and has existed for 2 years. Registered seat: Rönninge. Industry according to Statistics Sweden: temporary employment agency activities (SNI 78201).

How is the company doing financially?

Net sales in financial year 2026 were 1 047 765 kr, up 164 % on the previous year (397 496 kr). Net profit for 2026 was 226 561 kr (21,6 % of net sales). Employees in financial year 2026: 1. Net sales per employee were 1 047 765 kr. At the end of financial year 2026, total assets were 660 231 kr and equity 280 695 kr (equity ratio 42,5 %). The annual report for 2026 proposes a dividend of 200 000 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025/26

Proposed dividend 200 000 kr.

History
2025/26200 000 kr
2024/25150 000 kr
Summary of annual reports2025–2026
2024/252025/26
Sales revenue397 4961 047 765
Profit for the reporting year179 134226 561
Retained earnings of previous periods——
Total assets359 237660 231
Total liabilities155 103379 536
Total equity204 134280 695
Employees—1
Proposed dividend150 000200 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.